Crossmark

An optimized strategy triggered at the 2nd immunization visit to prevent HIV acquisition by breastfeeding: a phase 2 trial in Burkina Faso (PREVENIR-PEV)

Crossref DOI link: https://doi.org/10.1186/s12879-024-09910-z

Published Online: 2024-09-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mennecier, Anaïs

Sakana, Béninwendé Leticia Delphine

D’Ottavi, Morgana

Tassembedo, Souleymane

Moles, Jean-Pierre

Kania, Dramane

Taofiki, Ajani Ousmane

Kadeba, Franck Edgar

Diallo, Ibrahima

Eymard-Duvernay, Sabrina

Meda, Nicolas

Mosqueira, Beatriz

Fao, Paulin

Nagot, Nicolas

,

Vande Perre, Philippe
License Information

Text and Data Mining valid from 2024-09-20

Version of Record valid from 2024-09-20
More Information

Article History

Received: 3 April 2024

Accepted: 10 September 2024

First Online: 20 September 2024

Declarations

:

: The trial was approved by the Centre Muraz Ethics Committee (reference number:33) and the Ethics Committee for Health Research (CERS, number 2017–9-144) of Burkina Faso.A Data Safety Monitoring Committee monitored the trial until completion.Informed consent was obtained from all the participants and from the legal guardians of the participants who were below 16 years of age.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below